PharmX Technologies Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	7.44	7.32	6.49	6.13	5.39	11.88
Other Revenue	0.21	0.21	1.61	-	-	-
Revenue	7.65	7.53	8.09	6.13	5.39	11.88
Revenue Growth (YoY)	-11.41%	-6.97%	32.10%	13.78%	-54.65%	11.58%
Cost of Revenue	5.91	5.4	4.13	4.12	3.25	8.5
Gross Profit	1.73	2.13	3.96	2.01	2.14	3.38
Selling, General & Admin	1.07	0.84	2.64	1.7	1.15	0.98
Research & Development	-0.4	-0.32	-0.14	-0.09	-0.1	-0.62
Other Operating Expenses	-	-	-	-	0.09	0.02
Operating Expenses	2.45	2.02	3.72	2.67	2.01	2.16
Operating Income	-0.71	0.11	0.24	-0.67	0.13	1.22
Interest Expense	-0.03	-0.03	-0.04	-0.05	-0.01	-0.13
EBT Excluding Unusual Items	-0.74	0.08	0.2	-0.72	0.12	1.09
Gain (Loss) on Sale of Investments	-	-	-	-	-	1.73
Other Unusual Items	-	-	-	-	-	-1.47
Pretax Income	-0.74	0.08	0.2	-0.72	0.12	1.35
Income Tax Expense	0.19	0.34	0.11	0.16	0.25	0.27
Earnings From Continuing Operations	-0.93	-0.26	0.1	-0.88	-0.13	1.08
Earnings From Discontinued Operations	-	-	-1.86	-0.17	0.38	0.01
Net Income	-0.93	-0.26	-1.77	-1.05	0.25	1.09
Net Income to Common	-0.93	-0.26	-1.77	-1.05	0.25	1.09
Net Income Growth	-	-	-	-	-76.90%	519.89%
Shares Outstanding (Basic)	600	599	598	597	597	543
Shares Outstanding (Diluted)	600	599	598	597	601	547
Shares Change (YoY)	-1.26%	0.06%	0.17%	-0.56%	9.81%	57.55%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	0.00	0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	0.00	0.00
EPS Growth	-	-	-	-	-78.89%	300.60%
Free Cash Flow	0.98	-8.16	3.19	10.86	3.19	2.86
Free Cash Flow Per Share	0.00	-0.01	0.01	0.02	0.01	0.01
Gross Margin	22.66%	28.23%	48.98%	32.72%	39.74%	28.44%
Operating Margin	-9.32%	1.46%	3.02%	-10.85%	2.36%	10.28%
Profit Margin	-12.17%	-3.51%	-21.86%	-17.15%	4.68%	9.19%
Free Cash Flow Margin	12.79%	-108.38%	39.40%	177.23%	59.15%	24.10%
EBITDA	-0.32	0.4	0.53	-0.22	0.68	1.67
EBITDA Margin	-4.16%	5.26%	6.55%	-3.57%	12.61%	14.04%
D&A For EBITDA	0.4	0.29	0.29	0.45	0.55	0.45
EBIT	-0.71	0.11	0.24	-0.67	0.13	1.22
EBIT Margin	-9.32%	1.46%	3.02%	-10.85%	2.36%	10.28%
Effective Tax Rate	-	434.18%	52.74%	-	207.38%	19.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.